If you are unable to perform the injection yourself, you can visit the office for a weekly visit or we can train a family member to help you
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and subsequently approved by the FDA for chronic weight management
If youre exploring medical weight loss options, understanding the differences between these medications can help you have more informed conversations with your healthcare provider
High-sodium foods High-sodium foods, including salty snacks like chips, canned soups, cold cuts, and fast food, can contribute to water retention and interfere with efficient digestion
"Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists." Advances in Therapy , vol
Mistake 6: Stopping semaglutide too early Some people stop semaglutide a week or two before starting tirzepatide, creating an unnecessarily long gap